AbbVie has submitted an application to the FDA for the approval of TrenibotE — the first-in-class botulinum toxin type E. The product demonstrates a record-fast onset of action (8 hours) and a short duration of effect (2-3 weeks), which may change the approach to initial injections in patients who have previously avoided neurotoxins.

Sample informed consent form for the administration of Botox.

Article coming soon This page is under preparation and will be available soon.  

On the correction of a gummy smile, mimic wrinkles, and age-related changes in the lower third of the face and neck, as well as combined techniques for the use of botulinum toxin type A.

On the correction of mimic wrinkles and age-related changes in the upper third of the face (forehead, glabella, eyebrows, eyes, nose) using botulinum toxin type A.

Allergan Announces Results of Higher Dose BOTOX® Cosmetic (onabotulinumtoxin A) for the Treatment of Moderate to Severe Glabellar Lines.

In recent years, a trend has emerged toward undergoing rejuvenating procedures at an early age. The reasoning behind this is quite simple: early rejuvenation helps delay aging. But is this really the case?

A mapping scheme of the upper third of the face that is universal, effective, and safe for a beginner specialist. This method of marking injection points makes it possible to predict a favorable outcome of botulinum therapy for wrinkles in the upper third of the face.

Millions of botulinum toxin injections have been performed worldwide. However, not all of them were done with contraindications taken into account, and not all patients were satisfied with the results.